Plant-Based Antibacterial Agents against Pathogenic Bacteria: A Review on Mechanisms and Recent Developments

Background: Antimicrobial resistance (AMR) is a global health crisis that is outpacing discovery of new antibiotics. Plant-derived phytochemicals and plant-based formulations are promising sources of novel antibacterial agents that may act by multiple mechanisms and restore antibiotic efficacy. Objective: To synthesize plant-derived antibacterials addressing (1) primary phytochemical classes, (2) Molecular and cellular mechanisms against pathogenic bacteria, (3) Evidence for synergy with conventional antibiotics, (4) Nanotechnology-based delivery/optimization strategies, and (5) Translational progress and barriers. Methods: A systematic literature search of Scopus (primary), complemented by PubMed and Web of Science, was performed for reviews and original research published mainly in the last decade. Search strings combined terms such as “plant antimicrobial”, “phytochemical antibacterial”, “antimicrobial resistance”, “antibiofilm”, “synergy antibiotic plant”, and “nano-herbal”. Peer-reviewed Scopus-indexed articles and high-quality reviews were prioritized for synthesis. Results: Major phytochemical groups (phenolics/flavonoids, alkaloids, terpenoids/essential oils, tannins, and saponins) exhibit antibacterial activity through membrane disruption, nucleic acid/protein synthesis inhibition, efflux pump modulation, quorum sensing (QS) interference and anti-biofilm effects. Synergistic combinations of plant extracts or phytochemicals with antibiotics restore activity against resistant strains in vitro. Nano-encapsulation and nano-emulsions substantially improve phytochemical stability and bioavailability. However, variability of extracts, and few clinical studies hinder translation. Conclusion: This review supports a strong preclinical rationale for plant-derived antibacterials as adjuncts or alternatives to antibiotics, particularly against biofilms and multidrug-resistant (MDR) pathogens. Focused standardization, mechanism-guided isolation, optimized delivery (nano-systems), and rigorous in vivo and clinical validation are required for clinical translation.